WEDNESDAY,18 th NOVEMBER

RANBAXY
THE COMPANY IS AGAIN REGAINING ITS FAIR VALUE.
FDA PROBLEM HAVE BEEN RESOLVED AND COMPANY IS TRYING TO APPROACH FDA TO VISIT ITS FACILITY.
EXCHANGE RELATED LOSSES ARE ALSO NO CONCERN AS IT IS POSTING GAIN NOW
ON THAT FRONT.

RECOMMENDED PRICE TO BUY: 410
PRICE TARGET : 550
TIME FRAME : 12-14 MONTHS